HCPLive

Medical News

Daily news and information for physicians in a range of specialties and practice settings.

Latest Medical News

Higher Risk for Arrhythmia in Psoriasis Patients
Higher Risk for Arrhythmia in Psoriasis Patients
Patients suffering from psoriasis have a higher risk of developing arrhythmia – even after controlling for other risk factors, according to a study published in the Journal of the American Academy of Dermatology.
Psych Studies' Credibility Questioned
Reproducing study results can be difficult in any scientific field, but a study in the journal Science showed that confirming research in psychology is particularly challenging.
10 Reasons Why People Fear Physician Entrepreneurs
Physician entrepreneurship should not be feared, but encouraged. Yes, doctors can chew gum and walk at the same time and that's good for patients.
Flying Home for the Holidays? Why Thanksgiving Might Be Better Than Christmas
Holiday travel is often a costly proposition. However, it turns out you can save a lot of money if you're flexible about which holidays you fly home.
Luck Be A Lady…
"Luck" is a term often thrown around to explain away a good or bad event. But perhaps being "lucky" has nothing to do with luck.
Low Back Pain: Steroid Injections Do Not Provide Long-term Relief
While a common method used to treat low back pain may provide immediate relief, its effects do not extend for a substantial period of time, a new analysis has found.
Aspirin, NSAIDs May Decrease Colorectal Cancer Risk
Consistently using low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) could successfully diminish the risk of colorectal cancer (CRC) – the third most common cancer in the US.

Product News

Combo Cystic Fibrosis Therapy Approved
Combo Cystic Fibrosis Therapy Approved
The US Food and Drug Administration (FDA) on Thursday approved Orkambi (lumacaftor/ivacaftor/Vertex) to treat cystic fibrosis patients age 12 and older with two copies of the F508del mutation in the CFTR gene.
Hepatitis C: Good News on Genotype 1b Drug Combo
Results from the Turquoise III trial show an antiviral combo cured patients with chronic hepatitis C genotype 1b infections, according to data to be released June 26 at the International Symposium on Viral Hepatitis and Liver Diseases in Berline, Germany.
New Antiplatelet Drug Approved
The US Food and Drug Administration today approved the use of cangrelor (Kengreal/The Medicines Company) for adults undergoing percutaneous coronary interventions (PCI).
Brain Implant for Parkinson’s Disease Approved
The US Food and Drug Administration (FDA) granted approval for the Brio Neurostimulation System– the second brain implant stimulation device to aid in the reduction of Parkinson’s disease symptoms and essential tremor.
FDA Approves Toddler Use for Seizure Drug
The FDA extended the use of toparimate, an anti-seizure drug, to children as young as 2.

Most Popular

$vacMongoViewPlus$ $vAR$